(MedPage Today) — Incorporating more omega-3 fatty acids into the diet may decrease a woman’s risk of age-related macular degeneration (AMD), researchers found.
Category: News
Dietary Omega-3 Fatty Acid Intake Associated With Reduced Risk Of Age-Related Macular Degeneration In Women
Regular consumption of fish and omega-3 fatty acids found in fish is associated with a significantly reduced risk of developing age-related macular degeneration in women, according to a report posted online today that will appear in the June issue of A…
Stroke Incidence Higher Among Patients With Certain Type Of Retinal Vascular Disease
Patients with a disease known as retinal vein occlusion (RVO) have a significantly higher incidence of stroke when compared with persons who do not have RVO, according to a report in the March issue of Archives of Ophthalmology, one of the JAMA/Archive…
Role of Fixed Combinations in the Management of Open-Angle Glaucoma
Does 1 drop from 1 bottle once daily improve adherence? Expert Review of Pharmacoeconomics & Outcomes Research
European Patent Office grants ProtAffin key patent for CellJammer discovery technology
ProtAffin AG, a biotechnology company developing novel biopharmaceuticals for respiratory disease, inflammation and oncology, today announced that it has been granted a key patent by the European Patent Office protecting its CellJammer® discovery tech…
2011 RVO Evidence Update
NHS Evidence – eyes and vision has released its 2011 update on Retinal Vein Occlusion.
The update looks at new evidence that has emerged since the 2010 Update, for which guidance from NICE and the February 2009 interim guidance from the Royal Colleg…
Glaucoma Week Designed To Raise Awareness Of "Sneak Thief Of Sight"
Often referred to as the sneak thief of sight because it slowly causes vision loss, physicians and researchers at the Eugene and Marilyn Glick Eye Institute are trying to learn if glaucoma could be related to blood flow in the eye. Their discoveries co…
Vision Care In The Workplace
Our healthcare system is at a crossroads. With the recent reform of healthcare in the United States, we are seeing rising costs of healthcare and health insurance coverage. Employers are being forced to increase employees’ cost sharing responsibilities…
Choice Of LASIK, Lens Implantation Hinges On Assessment, Patient Selection
Meticulous preoperative assessment is critical to properly selecting patients for either LASIK or lens implantation and optimizing visual outcomes, a speaker said.
Choice Of LASIK, Lens Implantation Hinges On Assessment, Patient Selection
Meticulous preoperative assessment is critical to properly selecting patients for either LASIK or lens implantation and optimizing visual outcomes, a speaker said.
MS Drug May Increase Risk Of Macular Edema In Patients With Diabetes, Uveitis
A newly approved multiple sclerosis drug poses a potential risk of macular edema in patients with diabetes mellitus and a history of uveitis, a speaker said here.
Technolas Perfect Vision Receives FDA Approval Of Latest Technology For Custom LASIK
MUNICH, GERMANY–(Marketwire – March 14, 2011) – Technolas Perfect Vision GmbH (TPV), a cataract and refractive laser company at the forefront of providing advanced eye laser treatments, today announced that the U.S. Food and Drug Administration (FDA) …
MS Drug May Increase Risk Of Macular Edema In Patients With Diabetes, Uveitis
A newly approved multiple sclerosis drug poses a potential risk of macular edema in patients with diabetes mellitus and a history of uveitis, a speaker said here.
Unusual Corneal Topography: A Case Report
Technology Spotlight
Technolas Perfect Vision Receives FDA Approval Of Latest Technology For Custom LASIK
MUNICH, GERMANY–(Marketwire – March 14, 2011) – Technolas Perfect Vision GmbH (TPV), a cataract and refractive laser company at the forefront of providing advanced eye laser treatments, today announced that the U.S. Food and Drug Administration (FDA) …
Merck Announces FDA Acceptance Of New Drug Application For Investigational Ophthalmic Medication SAFLUTAN(R) (Tafluprost)
Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that the New Drug Application (NDA) for SAFLUTAN® (tafluprost), Merck’s investigational preservative-free prostaglandin analogue ophthalmic solution, has been accepte…
Roche’s Lucentis Helps Diabetics’ Vision
Diabetics suffering from macular edema can see better when treated with Roche’s eye drug Lucentis (ranibizumab injection), giving the medicine a slight lift ahead of another keenly awaited trial. Reuters Health Information
Anti-VEGF Drug Reverses Diabetic Vision Loss
(MedPage Today) — Patients headed toward blindness because of diabetic macular edema showed substantial gains in visual acuity after two years of treatment with the angiogenesis inhibitor drug ranibizumab (Lucentis), its manufacturer said.
Federal Incentives Prompt Providers to Replace Existing EHRs
More than one third of healthcare organizations buying electronic health record systems are ditching an existing one, according to a new survey by KLAS. Four vendors dominate the replacement market. Medscape Medical News
Genentech announces positive outcomes from Lucentis Phase III trial against DME
Genentech, a member of the Roche Group, today announced that two-year results from a pivotal Phase III trial showed patients with diabetic macular edema who received Lucentis experienced rapid and sustained improvement in vision compared to those who r…